Tratamento farmacológico hospitalar do infarto agudo do miocárdio com SUPRA de ST: SUS X Privado

Abstract

Background: In addition to reperfusion therapy, the use of medications for acute STEMI has great importance in reducing mortality from this disease. Objectives: To compare the adequacy of drug therapy in STEMI in public and private hospitals in Sergipe state in accordance with the Guideline of the ACCF / AHA for STEMI treatment. Methods: Prospective analysis of 471 patients admitted with acute myocardial infarction with ST - segment elevation in public and private hospitals in the state of Sergipe. Data were obtained from the VICTIM study enrollment Results: Clopidogrel usage fee (91% vs 36% ; p < 0.001 ) and ACE inhibitors (66% vs 22 %; p < 0.001 ) was significantly higher among SUS patients, however, use of ticagrelor (61% vs 1% ; p < 0.001 ) and BRA II (24% vs 9 %, p = 0.002 ) was higher among those treated in the private sector . In the pooled analysis, SUS patients received a significantly higher rate of ACEI and / or ARB II in those with an absolute indication for its use (76% vs 30%; p < 0.001). Conclusions: A significant difference was observed in the use of ACE inhibitors and / or ARBs among patients in both groups, a higher rate of use of these drugs was showed amongst SUS patients. In both groups, the rate of use of some medications is still much to be desired.